🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates how well panitumumab-IRDye800 and 89Zr-panitumumab wor...
Status
Completed
Location
Stanford Cancer Institute Palo Alto
Start Date
2019-01-07
Trial ID
NCT03733210
Treatments Being Tested
This study evaluates the safety and efficacy of intravenous injection of IS...
Status
Completed
Location
Hoag Memorial Hospital Presbyterian
Start Date
2024-01-17
Trial ID
NCT05954767
Treatments Being Tested
This is a Phase 1, single-site, interventional clinical trial evaluating th...
Status
Completed
Location
UCSF Medical Center, Mission Bay
Start Date
2020-10-10
Trial ID
NCT04574401
Treatments Being Tested
A Phase 1 Open Label Single Center Safety, Tolerability and Pharmacokinetic...
Status
Completed
Location
Las Palmas Medical Center
Start Date
2016-12
Trial ID
NCT03006237
Treatments Being Tested
This study evaluates the safety and feasibility of intravenous injection of...
Status
Completed
Location
St. David's North Austin Medical Center
Start Date
2023-06-14
Trial ID
NCT05769257
Treatments Being Tested
Lungs are made up of individual lobes. When a lung cancer tumour is detecte...
Status
Recruiting
Location
St. Joseph's Healthcare Hamilton
Start Date
2016-10
Trial ID
NCT02570815
Treatments Being Tested
This study evaluates the safety and efficacy of intravenous injection of IS...
Status
Completed
Location
George Washington University Hospital
Start Date
2019-05-28
Trial ID
NCT03937505
Treatments Being Tested
Phase 2 randomized controlled multi-center study of IS-002, in conjunction ...
Status
Completed
Location
UCSF
Start Date
2023-06-16
Trial ID
NCT05946603
Pancreas as well as Cholangiocarcinoma have a dismal prognosis at time of d...
Status
Completed
Location
Leiden University Medical Center
Start Date
2022-11-09
Trial ID
NCT05518071
Treatments Being Tested